Compare TWST & AVTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TWST | AVTR |
|---|---|---|
| Founded | 2013 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 10.5B |
| IPO Year | 2018 | 2019 |
| Metric | TWST | AVTR |
|---|---|---|
| Price | $161.33 | $15.72 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 16 |
| Target Price | ★ $150.33 | $14.85 |
| AVG Volume (30 Days) | 2.6M | ★ 8.5M |
| Earning Date | 11-13-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.89 | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | $376,572,000.00 | ★ $6,552,200,000.00 |
| Revenue This Year | $21.18 | $0.64 |
| Revenue Next Year | $20.16 | $2.29 |
| P/E Ratio | ★ N/A | $256.50 |
| Revenue Growth | ★ 20.32 | N/A |
| 52 Week Low | $23.30 | $7.27 |
| 52 Week High | $219.71 | $16.38 |
| Indicator | TWST | AVTR |
|---|---|---|
| Relative Strength Index (RSI) | 50.17 | 60.49 |
| Support Level | $41.18 | $14.57 |
| Resistance Level | N/A | $16.05 |
| Average True Range (ATR) | 15.71 | 0.47 |
| MACD | -4.20 | -0.03 |
| Stochastic Oscillator | 22.29 | 62.88 |
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.